The metabotropic glutamate receptor subtype 7 rs3792452 polymorphism is associated with the response to methylphenidate in children with attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 24, Issue 4, 2014, Pages 223-227

  Park, Subin ^a   Kim, Bung Nyun ^a   Cho, Soo Churl ^a   Kim, Jae Won ^a   Kim, Johanna Inhyang ^a   Shin, Min Sup ^a   Yoo, Hee Jeong ^a   Han, Doug Hyun ^b   Cheong, Jae Hoon ^c  

^a Seoul National University College of Medicine   (South Korea)

^b Chung Ang University   (South Korea)

^c Sahmyook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

METABOTROPIC RECEPTOR 7; METHYLPHENIDATE; CENTRAL STIMULANT AGENT; METABOTROPIC RECEPTOR;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILDHOOD DISEASE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RELEASE; DSM-IV; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OPEN STUDY; PROSPECTIVE STUDY; RATING SCALE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; ASIAN CONTINENTAL ANCESTRY GROUP; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE CONTROL STUDY; GENETICS; PSYCHOLOGICAL RATING SCALE; SOUTH KOREA; TREATMENT OUTCOME;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; GENOTYPE; HUMANS; MALE; METHYLPHENIDATE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, METABOTROPIC GLUTAMATE; REPUBLIC OF KOREA; TREATMENT OUTCOME;

EID: 84901274038     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2013.0079     Document Type: Article

References (30)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994
2. Biederman J, Faraone SV: Attention-deficit hyperactivity disorder. Lancet 366:237-248, 2005
3. Carrey N, MacMaster FP, Fogel J, Sparkes S, Waschbusch D, Sullivan S, Schmidt M: Metabolite changes resulting from treatment in children with ADHD: A 1H-MRS study. Clin Neuropharmacol 26:218-221, 2003
4. Cho SC, Kim BN, Kim JW, Kim HW, Choi HJ, Jung SW, Yang YH: The reliability and validity of diagnostic interview schedule for children version IV-Korean version (DISC-IV). J Korean Acad Child Adolesc Psychiatry 18:138-144, 2006
5. Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M: Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: Preliminary findings. J Neuropsychiatry Clinical Neurosci 16:63-69, 2004
6. Cunningham CE, Siegel LS, Offord DR: A dose-response analysis of the effects of methylphenidate on the peer interactions and simulated classroom performance of ADD children with and without conduct problems. J Child Psychol Psychiatry 32:439-452, 1991
7. DasBanerjee T, Middleton FA, Berger DF, Lombardo JP, Sagvolden T, Faraone SV: A comparison of molecular alterations in environmental and genetic rat models of ADHD: A pilot study. Am J Med Genet B Neuropsychiatr Genet 147B:1554-1563, 2008
8. DuPaul GJ: Parent and teacher ratings of ADHD symptoms-Psychometric properties in a community-based sample. J Clin Child Psychol 20:245-253, 1991
9. Froehlich TE, McGough JJ, Stein MA: Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics. CNS Drugs 24:99-117, 2010
10. Imperato A, Honore T, Jensen LH: Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: A study in freely-moving rats. Brain Res 530:223-228, 1990
11. Jin Z, Zang YF, Zeng YW, Zhang L, Wang YF: Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: A 1H-magnetic resonance spectroscopy study. Neurosci Lett 315:45-48, 2001
12. Kalivas PW: A role for glutamate transmission in addiction to psychostimulants. Addict Biol 5:325-329, 2000
13. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, Cho SC, Seo DH, Bae MO, So YK, Noh JS, Koh YJ, McBurnett K, Leventhal B: The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean version (K-SADS-PL-K). Yonsei Med J 45:81-89, 2004
14. Kinoshita A, Shigemoto R, Ohishi H, van der Putten H, Mizuno N: Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: A light and electron microscopic study. J Comp Neurol 393:332-352, 1998
15. Kosinski CM, Risso Bradley S, Conn PJ, Levey AI, Landwehrmeyer GB, Penney JB, Jr., Young AB, Standaert DG: Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia. J Comp Neurol 415:266-284, 1999
16. Lee SH, Kim SW, Lee MG, Yook KH, Greenhill LL, Fradin KN, Hong HJ: Lack of association between response of OROSmethylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD. Psychiatry Res 186:338-344, 2011
17. Leonard BE, McCartan D, White J, King DJ: Methylphenidate: A review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 19:151-180, 2004
18. MacMaster FP, Carrey N, Sparkes S, Kusumakar V: Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry 53:184-187, 2003
19. Markowitz JS, DeVane CL, Pestreich LK, Patrick KS, Muniz R: A comprehensive in vitro screening of d-, l-, and dl-Threo-methylphenidate: An exploratory study. J Child Adolesc Psychopharmacol 16:687-698, 2006
20. Mick E, Neale B, Middleton FA, McGough JJ, Faraone SV: Genomewide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B:1412-1418, 2008
21. National Institute of Mental Health: CGI, Clinical Global Impressions. Chevy Chase, MD: National Institute of Mental Health; 1970
22. Ozawa S, Kamiya H, Tsuzuki K: Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 54:581-618, 1998
23. Park KY, Jr., Park HJ: Korean educational developmental institute-Wechsler Intelligence Scale for Children (KEDI-WISC). Seoul: Korean Educational Development Institute, 2002
24. Park S, Jung SW, Kim BN, Cho SC, Shin MS, Kim JW, Yoo HJ, Cho DY, Chung US, Son JW, Kim HW: Association between the GRM7 rs3792452 polymorphism and attention deficit hyperactivity disorder in a Korean sample. Behav Brain Funct 9:1, 2013
25. Riedel G, Platt B, Micheau J: Glutamate receptor function in learning and memory. Behav Brain Res 140:1-47, 2003. (Pubitemid 36313239
26. Sagvolden T, Johansen EB, Woien G, Walaas SI, Storm-Mathisen J, Bergersen LH, Hvalby O, Jensen V, Aase H, Russell VA, Killeen PR, Dasbanerjee T, Middleton FA, Faraone SV: The spontaneously hypertensive rat model of ADHD-The importance of selecting the appropriate reference strain. Neuropharmacology 57:619-626, 2009
27. So YK, Noh JS, Kim YS, Ko SG, Koh YJ: The reliability and validity of Korean parent and teacher ADHD rating scale. J Korean Neuropsychiatr Assoc 41:283-289, 2002
28. Stein MA, McGough JJ: The pharmacogenomic era: Promise for personalizing attention deficit hyperactivity disorder therapy. Child Adolesc Psychiatr Clin N Am 17:475-490, xi-xii, 2008
29. Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, Logan J, Wong C, Ma Y, Swanson JM, Schulz K, Pradhan K: Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 34:1182-1190, 2007
30. Wanchoo SJ, Swann AC, Dafny N: Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate. Brain Res 1301:68-79, 2009